BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9682350)

  • 21. An
    Hoonakker M; Zariri A; de Brouwer L; David D; Borgman A; Sloots A
    Front Immunol; 2024; 15():1373411. PubMed ID: 38646535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay for rapid detection of toxins from Clostridium perfringens.
    Nagahama M; Kobayashi K; Ochi S; Sakurai J
    FEMS Microbiol Lett; 1991 Nov; 68(1):41-4. PubMed ID: 1769554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
    Bentancor AB; Halperin P; Flores M; Iribarren F
    J Infect Dev Ctries; 2009 Sep; 3(8):624-7. PubMed ID: 19801806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
    McClain MS; Cover TL
    Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
    Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
    Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of alpha-toxin gene of Clostridium perfringens type A and its primary immunological protective function].
    Xu CB; Xu CL; Zhao ZJ
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):624-8. PubMed ID: 17037067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANTIBODY RESPONSE TO EPSILON TOXIN OF CLOSTRIDIUM PERFRINGENS IN CAPTIVE RED DEER (CERVUS ELAPHUS) OVER A 13-MONTH PERIOD.
    Scala C; Duffard N; Beauchamp G; Boullier S; Locatelli Y
    J Zoo Wildl Med; 2016 Mar; 47(1):38-44. PubMed ID: 27010263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a flow cytometric bead immunoassay and its assessment as a possible aid to potency evaluation of enterotoxaemia vaccines.
    Buys A; Macdonald R; Crafford J; Theron J
    J S Afr Vet Assoc; 2014 Mar; 85(1):977. PubMed ID: 24832497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs.
    de la Rosa C; Hogue DE; Thonney ML
    J Anim Sci; 1997 Sep; 75(9):2328-34. PubMed ID: 9303449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Clostridium perfringens beta toxin by enzyme-linked immunosorbent assay.
    Martin PK; Naylor RD; Sharpe RT
    Res Vet Sci; 1988 Mar; 44(2):270-1. PubMed ID: 3387684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
    Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
    Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis.
    Kulkarni RR; Parreira VR; Sharif S; Prescott JF
    Clin Vaccine Immunol; 2007 Sep; 14(9):1070-7. PubMed ID: 17634510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium perfringens toxin types from wild-caught Atlantic cod (Gadus morhua L.), determined by PCR and ELISA.
    Aschfalk A; Müller W
    Can J Microbiol; 2002 Apr; 48(4):365-8. PubMed ID: 12030710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli.
    Goswami PP; Rupa P; Prihar NS; Garg LC
    Biochem Biophys Res Commun; 1996 Sep; 226(3):735-40. PubMed ID: 8831683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with a nontoxic naturally occurring Clostridium perfringens alpha toxin induces neutralizing antibodies in rabbits.
    Siqueira FF; Silva ROS; do Carmo AO; de Oliveira-Mendes BBR; Horta CCR; Lobato FCF; Kalapothakis E
    Anaerobe; 2018 Feb; 49():48-52. PubMed ID: 29246841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous flow immunosensor for highly selective and real-time detection of sub-ppb levels of 2-hydroxybiphenyl by using surface plasmon resonance imaging.
    Gobi KV; Tanaka H; Shoyama Y; Miura N
    Biosens Bioelectron; 2004 Sep; 20(2):350-7. PubMed ID: 15308241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.